Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury

Insights

Pericytes initiate inflammatory and fibrotic responses via MyD88 and IRAK4 signaling. Inhibiting this pathway in pericytes may treat fibrotic diseases and promote organ regeneration.

Area of Science:

  • Cell biology
  • Immunology
  • Regenerative medicine

Background:

  • Fibrotic diseases involve excessive matrix deposition, leading to organ dysfunction.
  • Pericytes, precursors to myofibroblasts, contribute to pathological matrix production and are potential therapeutic targets for fibrogenesis.
  • Tissue injury triggers inflammatory responses involving immune cells and resident cells.

Purpose of the Study:

  • To investigate the role of pericytes in inflammatory and fibrotic responses following tissue injury.
  • To identify molecular pathways regulating pericyte activation, migration, and differentiation into myofibroblasts.
  • To explore the therapeutic potential of targeting pericyte-specific signaling pathways for fibrotic disease treatment.

Main Methods:

  • Utilized mouse models of kidney injury.
  • Investigated pericyte activation of Toll-like receptor 2/4 (TLR2/4) and Myeloid differentiation primary response 88 (MyD88) pathways.
  • Examined the activation of the NLRP3 inflammasome and secretion of IL-1β and IL-18.
  • Assessed the impact of MyD88 ablation and IRAK4 inhibition on pericyte function and fibrogenesis in vivo.
  • Analyzed pericyte migration and differentiation into myofibroblasts.

Main Results:

  • Pericytes activate a TLR2/4- and MyD88-dependent inflammatory program upon tissue injury.
  • Pericytes engage the NLRP3 inflammasome, secreting IL-1β and IL-18, with IL-1β amplifying the response via pericyte MyD88.
  • MyD88 and its downstream kinase IRAK4 are critical intrinsic regulators of pericyte migration and myofibroblast differentiation.
  • Specific pericyte MyD88 ablation or pharmacological IRAK4 inhibition significantly protected against kidney injury by reducing tissue damage and myofibroblast activation/differentiation.

Conclusions:

  • MyD88 and IRAK4 are key regulators of both inflammatory and fibrogenic responses within pericytes.
  • Targeting the MyD88-dependent pathway in pericytes presents a potential therapeutic strategy to inhibit fibrogenesis and enhance organ regeneration.
  • These findings highlight pericytes as crucial mediators of injury response and potential targets for treating fibrotic conditions.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
17.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.8K
Inflammation01:38

Inflammation

Overview
63.4K